Published in Acta Obstet Gynecol Scand on January 01, 1990
Lymphocyte beta 2-adrenoceptors and adenosine 3':5'-cyclic monophosphate during and after normal pregnancy. Br J Pharmacol (1993) 0.75
Indoor radon exposure and risk of lung cancer: a nested case-control study in Finland. J Natl Cancer Inst (1996) 1.93
Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis (1994) 1.61
Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening. Fertil Steril (1996) 1.47
Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease. Prenat Diagn (1996) 1.46
Reproductive performance of women with uterine anomalies. An evaluation of 182 cases. Acta Obstet Gynecol Scand (1982) 1.41
Validity of self-reports of fractures in perimenopausal women. Am J Epidemiol (1999) 1.38
Weights of placentae from small-for-gestational age infants revisited. Placenta (2001) 1.32
High and unchanged sperm counts of Finnish men. Int J Androl (1996) 1.27
Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. Obstet Gynecol (1992) 1.26
Bone mineral density and risk factors for osteoporosis--a population-based study of 1600 perimenopausal women. Calcif Tissue Int (1994) 1.24
Diagnosis of genital human papillomavirus (HPV) lesions in the male: correlation of peniscopy, histology and in situ hybridisation. Genitourin Med (1993) 1.23
Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data. Eur J Epidemiol (1989) 1.20
Human papillomavirus (HPV) DNA sequences demonstrated by in situ DNA hybridization in serial paraffin-embedded cervical biopsies. Arch Gynecol (1986) 1.20
Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol (1997) 1.18
Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. Am J Obstet Gynecol (1996) 1.17
Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex Transm Dis (1990) 1.17
The influence of perinatal factors on breast feeding. Acta Paediatr Scand (1983) 1.16
Cervical papillomavirus infection progressing to invasive cancer in less than three years. Lancet (1985) 1.13
Malignant fibrous histiocytoma of the vulva. Gynecol Oncol (1987) 1.10
Calcaneal ultrasound predicts early postmenopausal fractures as well as axial BMD. A prospective study of 422 women. Osteoporos Int (2004) 1.10
Risk factors associated with cervical human papillomavirus infections: a case-control study. Am J Epidemiol (1993) 1.10
Natural history of cervical human papillomavirus (HPV) infections based on prospective follow-up. Br J Obstet Gynaecol (1985) 1.09
Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer. Br J Cancer (2000) 1.09
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer. Gynecol Oncol (2006) 1.09
The effect of gynecological risk factors on lumbar and femoral bone mineral density in peri- and postmenopausal women. Maturitas (1995) 1.09
Birth weight and sex of children and the correlation to the body burden of PCDDs/PCDFs and PCBs of the mother. Environ Health Perspect (1998) 1.06
Sexual behaviour of women with human papillomavirus (HPV) lesions of the uterine cervix. Br J Vener Dis (1984) 1.05
Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer. J Clin Oncol (1998) 1.05
Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners. Sex Transm Dis (1997) 1.05
Prognostic factors in cervical human papillomavirus infections. Sex Transm Dis (1992) 1.05
Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR. Gynecol Oncol (1999) 1.04
Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol (1994) 1.03
PCDD, PCDF, and PCB concentrations in human milk from two areas in Finland. Chemosphere (1997) 1.03
Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables. Cancer Genet Cytogenet (2000) 1.03
Risk factors for perimenopausal fractures: a prospective study. Osteoporos Int (2000) 1.03
Genital human papillomavirus lesions of the male sexual partners: the diagnostic accuracy of peniscopy. Genitourin Med (1991) 1.02
Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study. Ann Rheum Dis (1994) 1.01
Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis (1997) 1.01
Relationships between risk factors and fractures differ by type of fracture: a population-based study of 12,192 perimenopausal women. Osteoporos Int (1998) 1.01
Perinatal diagnostic evaluation of velamentous umbilical cord insertion: clinical, Doppler, and ultrasonic findings. Obstet Gynecol (1996) 1.01
Factors associated with progression of cervical human papillomavirus (HPV) infections into carcinoma in situ during a long-term prospective follow-up. Br J Obstet Gynaecol (1988) 0.99
Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy. J Bone Miner Res (2000) 0.98
Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial. J Clin Endocrinol Metab (1999) 0.98
Human papillomavirus (HPV) infections involved in the neoplastic process of the uterine cervix as established by prospective follow-up of 513 women for two years. Eur J Gynaecol Oncol (1987) 0.97
p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer. Br J Cancer (1999) 0.97
Risk factors for perimenopausal distal forearm fracture. Osteoporos Int (2000) 0.96
Cytomegalovirus hepatitis in late pregnancy. Int J Gynaecol Obstet (1992) 0.96
Fractures and low axial bone density in perimenopausal women. J Clin Epidemiol (1995) 0.94
HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial. Maturitas (1998) 0.93
Amniotic fluid U. urealyticum colonization: significance for maternal peripartal infections at term. Am J Perinatol (1997) 0.93
Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem Pharmacol (1996) 0.93
Prediction of fracture risk using axial bone mineral density in a perimenopausal population: a prospective study. J Bone Miner Res (1995) 0.93
Prospective follow-up of genital HPV infections: survival analysis of the HPV typing data. Eur J Epidemiol (1990) 0.93
Polymerase chain reaction amplification of human papillomavirus DNA from archival, Papanicolaou-stained cervical smears. Acta Cytol (1996) 0.92
Lead, magnesium, selenium and zinc in human seminal fluid: comparison with semen parameters and fertility. Hum Reprod (1987) 0.92
Risk of obstetric cholestasis in sisters of index patients. Clin Genet (2001) 0.92
Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers. Biol Neonate (2001) 0.92
Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus. Am J Obstet Gynecol (1973) 0.91
Evolution of human papillomavirus infections in the uterine cervix during a long-term prospective follow-up. Appl Pathol (1987) 0.91
Human papillomavirus (HPV) type as an important determinant of the natural history of HPV infections in uterine cervix. Eur J Epidemiol (1985) 0.90
Risks of perimenopausal fractures--a prospective population-based study. Acta Obstet Gynecol Scand (1995) 0.89
Accumulation of cadmium, zinc, and copper in maternal blood and developmental placental tissue: differences between Finland, Estonia, and St. Petersburg. Environ Res (2000) 0.89
Early pregnancy loss and exposure to 50-Hz magnetic fields. Bioelectromagnetics (1993) 0.89
Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer. Tumour Biol (2007) 0.89
Osteoporosis risk factors, gynaecological history and fractures in perimenopausal women--the results of the baseline postal enquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas (1993) 0.88
Lifestyle and other factors predict ankle fractures in perimenopausal women: a population-based prospective cohort study. Bone (2002) 0.88
Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. Calcif Tissue Int (1998) 0.88
Induction of labour with sulprostone after foetal death and in hydatidiform mole. Prostaglandins (1980) 0.88
Clinical course and prognostic factors of human papillomavirus infections in men. Sex Transm Dis (1995) 0.88
C-reactive protein (CRP) levels after normal and complicated caesarean section. Ann Chir Gynaecol (1989) 0.88
Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3. Maturitas (1995) 0.87
Deletion in the FMR1 gene in a fragile-X male. Am J Med Genet (1996) 0.87
Intrapartum rupture of uterus diagnosed by ultrasound: a case report. Int J Gynaecol Obstet (1984) 0.87
Systemic alpha-interferon (Wellferon) treatment of genital human papillomavirus (HPV) type 6, 11, 16, and 18 infections: double-blind, placebo-controlled trial. Gynecol Oncol (1991) 0.86
Smoking does affect fecundity. Eur J Obstet Gynecol Reprod Biol (1990) 0.86
The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women. J Bone Miner Res (2000) 0.86
Variants of the long control region of human papillomavirus type 16. Eur J Cancer (2000) 0.86
Cryotherapy and CO2-laser vaporization in the treatment of cervical and vaginal human papillomavirus (HPV) infections. Acta Obstet Gynecol Scand (1989) 0.86
Immunophenotypes of lymphocytes in prospectively followed up human papillomavirus lesions of the cervix. Genitourin Med (1985) 0.85
Cigarette smoking and semen quality in men of reproductive age. Andrologia (1988) 0.85
Langerhans cells in human papillomavirus (HPV) lesions of the uterine cervix identified by the monoclonal antibody OKT-6. Int J Gynaecol Obstet (1984) 0.85
Clinical course of cervical human papillomavirus lesions in relation to coexistent cervical infections. Sex Transm Dis (1992) 0.85
Treatment of imminent premature labour. Acta Obstet Gynecol Scand (1975) 0.85
The effect of previous oral contraceptive use on bone mineral density in perimenopausal women. Osteoporos Int (1994) 0.84
Risk of placental abruption in first-degree relatives of index patients. Clin Genet (2004) 0.83
Cervical smears in assessment of the natural history of human papillomavirus infections in prospectively followed women. Acta Cytol (1988) 0.83
Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial. Osteoporos Int (2000) 0.83
Velamentous umbilical cord insertion may be suspected from maternal serum alpha-fetoprotein and hCG. Br J Obstet Gynaecol (1996) 0.82
Chlamydial cervicitis in women followed-up for human papillomavirus (HPV) lesions of the uterine cervix. Acta Obstet Gynecol Scand (1985) 0.82
Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study. Am J Obstet Gynecol (2001) 0.82